Mesothelioma Foundation Expert Can Answer Your Questions!

Nurse Practitioner, Mary Hesdorffer, is a mesothelioma expert and has worked with mesothelioma patients and their families for the past twelve years. Mary is available to answer your questions about mesothelioma, its symptoms and treatments as well as options available to you. This help is a free service provided by the Mesothelioma Applied Research Foundation. We are not a law firm. Read more about the Mesothelioma Applied Research Foundation.

TO GET HELP CALL: (877) End-Meso or (877) 363-6376 or fill out the form to the right to be contacted by her.

Facebook Twitter YouTube Google Plus

Mesothelioma Resources | Mesothelioma Podcast Series

Meet the Mesothelioma Experts

As part of the Meet the Mesothelioma Experts series, the Meso Foundation invites specialists in the field of mesothelioma to discuss their current research interests as well as promising developments in the treatment of mesothelioma. Below, you can view and register for the upcoming session and you can also listen to audio files of past sessions. If you wish to receive emails from the Meso Foundation, including alerts about new installments of the Meet the Mesothelioma Experts series, please click here.

Upcoming Session:

Check back soon for details about our next session of the Meet the Mesothelioma Experts series.

Past Session Podcasts:

Mesothelioma Clinical Trial Using PD-L1 Inhibitors
Dr. Evan Alley of the University of Pennsylvania discusses his new clinical trial for pleural mesothelioma patients, which is looking into an agent that would inhibit the PD-L1 protein.

Defactinib, a New Investigational Agent for Mesothelioma
Dr. Joanna C. Horobin of Verastem, Inc. discusses the company’s latest investigational agent, defactinib, which is being developed for use in patients with pleural mesothelioma.

Focused Discussion of a New Clinical Trial: GL-ONC1
Dr. Valerie Rusch of the Memorial Sloan Kettering Cancer Center discusses her new clinical trial for mesothelioma patients, GL-ONC1.

New Frontiers in Surgery for Mesothelioma
Dr. Joseph Friedberg of the University of Pennsylvania discusses mesothelioma surgery with an emphasis on photodynamic therapy, a type of treatment that uses light therapy to destroy cancer cells.

Designing Clinical Trials for Mesothelioma
Melissa Culligan, RN, BSN, MS, of the University of Pennsylvania discusses what goes into designing mesothelioma clinical trials.

Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma
Dr. Tobias Peikert of the Mayo Clinic discusses his clinical trial, which uses the measles virus to attack mesothelioma cells in pleural mesothelioma patients.

NGR-hTTNF: A New Multi-Center Drug Trial for Pleural Mesothelioma
Dr. Julie Brahmer of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital discusses her clinical trial, which uses a new chemotherapy treatment designed specifically for pleural mesothelioma patients.

Mesothelin: A New Target for Immunotherapy
Dr. Raffit Hassan of the National Cancer Institute discusses his research into mesothelin and development of clinical trials using mesothelin as a target for epithelial malignant mesothelioma, providing both pleural and peritoneal mesothelioma patients with the potential of much-needed new treatment options.

Recent Advances in Mesothelioma Gene Therapy
Dr. Daniel Sterman of the University of Pennsylvania discusses recent advances in the field of mesothelioma gene therapy.

Vaccines: can we manipulate the immune system to prevent recurrence following a PD/EPP?
Dr. Lee Krug of the Memorial Sloan Kettering Cancer Center discusses a clinical trial that answers the title questions.

**Any call conferencing and/or unauthorized transmission, broadcast, retransmission, rebroadcast, or republishing of the podcasts without the express written consent of the Mesothelioma Applied Research Foundation is strictly prohibited and may be illegal.

/* This button was generated using CSSButtonGenerator.com */